Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis.

J Comp Eff Res · 2025 · PMC12007476 · PMID 40095567

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Sensitivity analyses The results of the sensitivity analysis that used the MCS rather than the MMS for ELEVATE trials to measure efficacy outcomes did not result in any significant differences between treatment comparisons with ETS2 compared with the main analyses for efficacy outcomes other than some borderline significant results ( Supplementary Material 8 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.